CClinicalTrials.gg
Not yet recruitingNCT07107282Updated Aug 6, 2025

Evaluation of a Software to Predict the Postoperative Component Position in Total Hip Arthroplasty (THA)

An observational study in Total Hip Arthroplasty, sponsored by Marcel Jakob. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-06.

Sponsored by Marcel Jakob · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn about the accuracy of a software determining the implant position during THA surgery.

Measurements made with the software are compared to reference values determined on X-rays.

Read the detailed description

The software is based on comparing an pre-operative fluoroscopy-based image with inter-operative fluoroscopy-based image. Three numerical values are provided: "leg length", "lateral offset" and "inclination".

Correponding reference values are determined based on pre-operative and post-operative X-rays.

02

Conditions studied

  • Total Hip Arthroplasty

Keywords

  • implant position
  • leg length
03

In context

Lead sponsor

This is the only study on the registry with Marcel Jakob as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing total hip arthrosplasty

Inclusion criteria

  1. Scheduled for THA
  2. Age of 18 or above

Exclusion criteria

Exclusion Criteria:

  1. Patients with anatomical conditions which reduce the applicability of the software
  2. Patients with implants which reduce the applicability of the software
  3. Patients who cannot perform an upright X-ray
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • All patients

    All patients included in the study

    Device: MyHip Verifier

Interventions

  • DeviceMyHip Verifier

    Numerical information on the position of the implant is provided to the surgeon.

06

What researchers measure

Primary outcomes

  1. Mean absolute difference between measured value and reference value

    The mean absolute difference between the final value measured by the software and the reference value determined on a postoperative X-ray.

    Time frame: This measure involves two time points: Stopping of the software during surgery and performing the postoperative X-ray. The latter is usually the first day after surgery. A delay is allowed if a patient cannot perform an upright X-ray.

Secondary outcomes

  1. Mean amount of repositioning performed by the surgeon

    The mean absolute difference between the value measured by the software when started and the final value

    Time frame: This measure involves two time points: Starting and stopping of the software during surgery.

  2. Mean absolute improvement in reaching the target value

    The mean value of the change in absolute difference between the actual position and the target value from starting the software until stopping the software.

    Time frame: This measure involves three time points: Determining target values prior to surgery and starting and stopping the software during surgery,

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — An anonymized version of the statistical analysis data set will be published as part of the main publication.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07107282
Lead sponsor
Marcel Jakob
Collaborators
Basel Academy for Quality and Research in Medicine
Responsible party
Marcel Jakob (Prof. Dr., crossklinik AG) — Sponsor-investigator
First posted
Aug 6, 2025
Start date
Sep 2025 (estimated)
Primary completion
Jun 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Aug 6, 2025

Study contacts

Marcel Jakob, MD
Contact
marcel.jakob@crossklinik.ch
+41 61 285 1042
Werner Vach, PhD
Contact
werner.vach@basel-academy.ch
+41 61 285 1034
Marcel Jakob, MD
principal investigator · crossklinik AG

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion